Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-04-13

FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Oceanside Pharmaceuticals)

View source ↗

Summary

The FDA approved Oceanside Pharmaceuticals' supplemental NDA for metformin hydrochloride, resulting in updated labeling for this product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METFORMIN HYDROCHLORIDE (Metformin hydrochloride)

Snippet

SUPPL AP for METFORMIN HYDROCHLORIDE (METFORMIN HYDROCHLORIDE)